Related Experiment Video
Updated: Jul 12, 2025
08:21
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
6.9K
GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell
Nour Zaïmia1, Joelle Obeid1, Annie Varrault1
1IGF, Université Montpellier, CNRS, INSERM, Montpellier, France.
Cell Reports
|October 28, 2023
Summary
Beta-arrestin 2 (ARRB2) plays distinct roles in regulating GLP-1R and GIPR signaling, impacting glucose homeostasis. Understanding ARRB2
Area of Science:
- Endocrinology and Metabolism
- Molecular Cell Biology
- G-protein coupled receptor signaling
Background:
- Glucagon-like peptide 1 (GLP-1R) and glucose-dependent insulinotropic polypeptide (GIPR) are key regulators of glucose homeostasis.
- Diabetogenic conditions are associated with reduced levels of beta-arrestin 2 (ARRB2) in human islets.
- ARRB2 is a critical mediator in G-protein coupled receptor (GPCR) signaling pathways.
Purpose of the Study:
- To elucidate the distinct roles of ARRB2 in GLP-1R and GIPR signaling.
- To investigate the functional consequences of decreased ARRB2 expression in diabetes.
- To assess the signaling pathways engaged by biased and dual GLP-1/GIP agonists for therapeutic potential.
Main Methods:
- Investigated ARRB2's role in GLP-1R and GIPR signaling in mouse and human islet cells.
- Analyzed the impact of ARRB2 on cAMP/PKA and ERK signaling pathways.
- Examined the GIPR-ARRB2 axis's involvement in F-actin depolymerization and insulin secretion.
Main Results:
- In mouse β cells, ARRB2 dampens GLP-1R signaling at physiological doses but is required for ERK activation at pharmacological doses.
- GIP-potentiated insulin secretion in both mouse and human islets requires ARRB2, independent of cAMP/PKA or ERK pathways.
- The dual agonist tirzepatide potentiates insulin secretion independently of ARRB2.
Conclusions:
- ARRB2 exhibits differential regulation of GLP-1R and GIPR signaling pathways.
- Reduced ARRB2 levels in diabetes may impair glucose homeostasis.
- Therapeutic strategies targeting GLP-1R and GIPR should consider ARRB2's distinct roles and agonist-specific signaling biases.
Related Concept Videos
01:24Glucagon-like Receptor Agonists
334
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
334
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
01:25cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K